Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide injection) produces measurable weight loss in clinical settings, with the STEP trials showing average reductions of 15 to 22 percent of baseline body weight. Real-world outcomes vary widely based on individual physiology, commitment to lifestyle changes, and genetic predisposition to GLP-1 sensitivity. Understanding these factors helps set achievable goals and choose the right treatment strategy.

Clinical Trial Data: Wegovy Weight Loss Outcomes

The STEP clinical trials, which established Wegovy's safety and effectiveness, enrolled over 4,500 adults with obesity or overweight with weight-related conditions. Participants receiving the highest maintenance dose (2.4 mg weekly) lost an average of 15.3 kg (about 22 percent of body weight) compared to 2.6 kg in the placebo group over 68 weeks. These results represent the most robust evidence available for semaglutide's weight-loss capacity in a controlled setting.

Not all participants achieved the maximum weight loss shown in trials. Approximately 50 to 60 percent of patients on Wegovy reached clinically significant weight loss (5 percent or more), while response rates varied by individual baseline weight, age, and metabolic health. The trial data suggests that genetics, insulin resistance, and gut hormone sensitivity play important roles in determining individual response to the medication.

Factors Affecting Individual Weight Loss on Semaglutide

Genetic variation in GLP-1 receptor expression influences how effectively semaglutide works for each person. Some individuals carry genetic variants (such as GLP1R rs6923761) associated with higher or lower baseline GLP-1 sensitivity, which can predict stronger or weaker appetite suppression. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and identifies 150+ genetic insights that reveal your unique peptide-pathway profile, helping clinicians optimize treatment selection and dosing strategy.

Dose escalation timing, dietary adherence, physical activity level, and sleep quality all influence final weight loss outcomes. Patients who reach the full 2.4 mg maintenance dose and maintain consistent nutrition habits typically achieve results closer to the trial average. Starting semaglutide at lower doses and gradually increasing allows the body to adapt and improves tolerability, which supports long-term medication adherence and better results.

Compounded Semaglutide vs. Brand-Name Wegovy

Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as brand-name Wegovy, meaning the weight-loss mechanism and clinical outcomes are equivalent. PlexusDx sources all compounded semaglutide from certified 503A compounding facilities that follow strict quality, sterility, and potency standards. Starting at just $149 per month, compounded semaglutide makes sustained treatment accessible without insurance requirements or membership fees.

Brand-name Wegovy carries a higher out-of-pocket cost for most uninsured patients and those with high deductibles. PlexusDx compounded semaglutide injection works identically from a physiological standpoint—the medication binds to GLP-1 receptors in the hypothalamus and gut, slowing gastric emptying and reducing hunger signals. HSA and FSA accounts can be used to cover the cost, providing additional savings for eligible individuals.

Realistic Weight Loss Goals and Timeline

Most patients begin noticing appetite reduction and modest weight loss (2 to 4 pounds) within the first 2 to 4 weeks of starting semaglutide. Meaningful weight loss (10 to 15 pounds) typically accumulates over 8 to 12 weeks, with the steepest rate of loss occurring between weeks 8 and 24 as the dose reaches therapeutic levels. Weight loss typically plateaus after 6 to 12 months, at which point most individuals remain weight-stable or lose more slowly if dietary adherence continues.

Individual variation means some patients lose 20 or more pounds while others lose 5 to 10 pounds over the same timeframe. Factors like starting weight, baseline metabolic rate, thyroid function, and whether insulin resistance is present all shape the trajectory. Setting personalized goals based on your genetic profile, health history, and medical team guidance—rather than comparing yourself to trial averages—creates more sustainable motivation and prevents discouragement if your response differs from published data.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the maximum amount of weight someone lost on Wegovy in clinical trials?

The STEP trials documented average weight loss of 15 to 22 percent of baseline body weight (approximately 15 to 20 kg) in participants taking the 2.4 mg maintenance dose over 68 weeks. Some individual participants lost more, and some lost less, depending on genetics, lifestyle, and treatment adherence. Real-world data outside controlled trials shows similar variability.

How long does it take to see weight loss results on Wegovy?

Most patients notice reduced appetite and modest weight loss within 2 to 4 weeks of starting semaglutide. Clinically significant weight loss (5 to 10 pounds or more) typically accumulates over 8 to 12 weeks as the dose escalates. Peak weight loss rates usually occur between months 2 and 6 of consistent treatment.

Does PlexusDx compounded semaglutide produce the same weight loss as brand-name Wegovy?

Yes. PlexusDx compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and produces the same physiological effects as brand-name Wegovy. Starting at $149 per month with no membership fees or insurance required, compounded semaglutide makes effective treatment more affordable while delivering equivalent weight-loss outcomes.

Why do some people lose more weight than others on semaglutide?

Genetic variation in GLP-1 receptor sensitivity, baseline insulin resistance, dietary adherence, physical activity level, and sleep quality all influence individual weight-loss response. PlexusDx's Precision Peptide Genetic Test identifies your unique genetic profile across 14 metabolic pathways, helping predict your likelihood of strong versus moderate semaglutide response and optimizing your treatment plan.

What happens to weight loss after stopping Wegovy?

Weight typically regains over 6 to 12 months after stopping semaglutide, though most patients maintain some weight loss long-term if they sustain improved eating habits and activity. This is why ongoing treatment with PlexusDx compounded semaglutide ($149/mo) or other GLP-1 options supports sustained results without the financial burden of brand-name medications.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves